Algen Biotechnologies
YC W20Using CRISPR to find treatments for cancer and inflammation
San Francisco, CA, USAFounded 202515 employeeswww.algenbio.com
Team
15
Founded
2025
About
Algen is using CRISPR to uncover disease-driving RNA messages to find treatments for cancer, inflammation and diseases with high unmet needs. We are harnessing the power of CRISPR and machine learning to find first-in-class drugs that modulate RNA messages at single-cell resolution. Algen's founders are bioengineer from Jennifer Doudna Lab and biotech commercialization expert, teamed up with experienced pharmaceutical executives.
No open roles at this time.
Similar Healthcare startups
Ansa Biotechnologies
Next-generation DNA synthesis using enzymes
Synthetic BiologyBiotech
Open Jobs —
Team 72
Founded 2022
Numerion Labs
Artificial intelligence for drug discovery.
AI-powered Drug DiscoveryDeep LearningBiotech
Open Jobs —
Team 67
Founded 2014
Menten AI
Menten AI designs peptide and protein therapeutics using quantum…
AI-powered Drug DiscoveryQuantum Computing
Open Jobs —
Team 2
Founded 2020
Rosebud Biosciences
Growing micro-organs to find new drugs
AI-powered Drug DiscoveryPediatricsBiotech
Open Jobs —
Team 3
Founded 2022